Adverse ocular effects of anticonvulsants.
With increasing recognition of the interface between neurology and psychiatry, the use of anticonvulsants to treat the signs and symptoms of many psychiatric disturbances is becoming commonplace. Although rare adverse reactions, such as those in the hepatic and hematological systems, have attracted considerable concern, for many anticonvulsants it is the ocular reactions that are among the most common. This article reviews the major ocular reactions to anticonvulsants and suggests guidelines for their use. It also underscores the importance of including adverse ocular effects as part of the informed consent process.
Goldman
M J
MJ
Gaughan Fellowship in Forensic and Correctional Psychiatry/Bridgewater State Hospital, Harvard Medical School, Boston, MA.
Schultz-Ross
R A
RA
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005128:Eye Diseases / Q000139:chemically induced*; D006801:Humans; D015835:Ocular Motility Disorders / Q000139:chemically induced*; D012307:Risk Factors; D014786:Vision Disorders / Q000139:chemically induced*
D000927:Anticonvulsants